How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

Pre-clinical data supporting immunotherapy for HIV using CMV-HIV-specific CAR T cells with CMV vaccine: Molecular Therapy - Methods & Clinical Development

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8+ antigen-specific T cells for adoptive immunotherapy: Molecular Therapy - Methods & Clinical Development

In vitro functional assays to augment immunotherapy research

Steps involved in establishing human immune system (HIS) models in

Preclinical Cancer Model Systems Hale Family Center For Pancreatic Cancer Research

A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases - eBioMedicine

Gene therapy approaches against cancer using in vivo and ex vivo gene transfer of interleukin-12

Overcoming delivery barriers in immunotherapy for glioblastoma

Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV- specific CD8+ T cells in people living with HIV - eBioMedicine

Intratumoural administration and tumour tissue targeting of cancer immunotherapies

Combination therapy with CAR T cells and oncolytic viruses: a new era in cancer immunotherapy